As discussions on the General Pharmaceutical Legislation come to a head, Europe faces two choices: becoming a leader in innovative research, development and manufacturing, or losing its global standing.
If the continent plays its cards right, the necessity of defense could turn out to be the mother of invention.
The Trump administration has touted investments to reassure Americans who are uneasy about his tariffs. But economic development officials say those investments have slowed amid economic uncertainty.
The European Union on Wednesday gave its go-ahead for a new, large-scale industrial policy project on nuclear technologies. At least four member countries will be able to design and spearhead a so-called “Important Project of Common European Interest” (IPCEI) on nuclear, EU governments and the European Commission decided at a high-level forum in Brussels. Twelve […]
The pandemic showed just what can be achieved with faster and more efficient regulatory approval — the same approach needs to be applied now to save patients’ lives and tackle the growing burden of Alzheimer’s disease.
The U.K. hopes teaming up with the U.S. on advanced tech might help avoid the president’s tariff wrath.
From AI to edge cloud, the EU must become stronger in the global telecom value-chain
AU MENU — Le deal gagnant-gagnant des opérateurs télécoms avec des IA génératives. — Les datacenters ont les yeux plus gros que le ventre, selon RTE. — Protection des données : la CNIL se rode face aux modèles d’IA, avec Mistral pour cas pratique. Bonjour à toutes et à tous, nous sommes vendredi 14 février. […]
SNEAK PEEK — Where does the Paris summit leave the U.K.’s AI policy? — MPs tackle the data bill, amendments and all. — Patrick Vallance sets out his plan to remake science. Good morning and welcome to Wednesday, This is Tom, heading back to London from a gloomy City of Light. Come and say hi if you’re […]
The European Union has pivoted to cheering AI innovation, laying less emphasis on rules that curb potential threats.
U.K. prime minister also wants the EU to target Russia’s energy revenues to keep the pressure on “rattled” leader Vladimir Putin.
A feel-good photo op just triggered a billionaire slapfight. Here’s what’s really at stake.
We can’t make true progress on unmet medical needs unless we understand what the patients themselves think they need or say is missing from their treatment options.
Stagnation, flagging competitiveness, Donald Trump — the continent is facing “an existential challenge.”
AI and data-driven innovation will allow the beauty sector to personalise products based on individual preferences and needs while advancing carbon neutrality goals.
The post Europe’s beauty companies reinvesting 5% of sales in R&D for Green Deal g…
The European cosmetics and personal care sector, valued at €96 billion and supporting over 3.5 million jobs, faces significant challenges due to regulatory complexities and limited support for innovation.
The post EU’s beauty sector growth threat…
Europe’s pharmaceutical sector has grown slowly for 25 years and its share of research is shrinking. It’s time to turn things around
With competitiveness lagging, the EU must take urgent, decisive action to reignite the region’s economy
Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment of €15.5 million, according to the latest figures from pharma.be.
The EU’s Standard-Essential Patent (SEP) proposal aims to streamline licensing but critics warn it could stifle innovation, weaken R&D incentives, and complicate involvement for SMEs.
Over the years, Europe’s share of global medicine R&D investments has dropped. However, with the new EU mandate, there is a chance to turn this around
The “trusted” network includes 71 members.
Researchers celebrated a big post-Brexit deal to rejoin Horizon. Now they fear they will end up footing the bill.
Simpler, faster, better – let’s not miss the opportunity to revamp the EU pharmaceutical regulatory framework to transform lives.
The narrow definition of unmet medical need used in the General Pharmaceutical Legislation may hinder rather than help efforts to find new treatments.
A report, seen by Euractiv, drafted by large EU defence companies eying the reform of the European Defence Fund calls out governments for not supporting projects financially and for a lack of long-term perspective for their projects.
Despite calls to step up efforts, investment in antimicrobial resistance is still insufficient.
Le rapport Draghi est plein de bonnes intentions pour redresser un continent en perte de vitesse. Mais si la vision est audacieuse, la politique le rend pratiquement impossible à appliquer.
The Draghi report is full of good intentions to mend a continent losing its way. But while the vision is bold, the politics are practically impossible.
We have an important chance to regain Europe’s edge in one of its most important sectors – and, in turn, help people live longer and feel better.
Concerns about Chinese ownership impacted government’s thinking to keep microchips factory afloat.
There is a moral imperative to make scientific research freely available. Publicly funded research should be publicly accessible. Accelerating research availability can save lives, support researchers’ careers, and create a brighter future.
Package includes measures to boost corporate investment, tax incentives for R&D and plans for longer working hours
The Labour leader says he wants to secure a better deal with the EU on trade, R&D as well as security and defence.
As this competition is ultimately a race for progress, wealth and geostrategic influence, its importance for the Continent’s future cannot be overvalued.
European intellectual property policies are weakening Europe’s competitive edge at the very moment that EU leaders have recognized the importance of restoring the region’s status as a global economic superpower.
With Brussels gunning for a leading role on defense, NATO officials worry about overlaps with the military alliance.
Iliana Ivanova, European Commissioner for Innovation, Research, Culture, Education and Youth shared with Euractiv in an interview her views on how to fill the gap in financing of science and innovation in the member states which stands at €100 billion …
Trade and tech dialogue would likely not survive a Trump return — and that would threaten fragile transatlantic solidarity on how to deal with China.
Knowing about the massive amounts of spying taking place can make one paranoid. But the best antidote to widespread espionage isn’t fear — it’s awareness.
The authors regularly advise the automotive and IT/tech industry. The views expressed in this article are personal. As things stand now, European manufacturers are at a disadvantage, as patent owners from around the world can exclude devices that implement standards from the market unless manufacturers give in to their royalty demands. The proposed EU SEP […]
Drone armies, expanded overtime pay and over-the-counter birth control pills are just some of the new things Biden has ushered in as president that you might not have heard about.
Welcome to Euractiv’s Tech Brief, your weekly update on all things digital in the EU. You can subscribe to the newsletter here.
The European Commission will propose several options for promoting research and development (R&D) related to technologies with dual-use potential, namely, those that can be used for both civil and military purposes, such as drones and satellites.
Astronauts aboard the International Space Station are using microgravity to unlock the disease’s secrets.
Innovation only matters if it reaches patients.
A wave of concerning policies around the globe that are currently being implemented or are under discussion will, if the trend continues, have a profoundly negative impact on patients.
The ongoing review of the EU Pharmaceutical Legislation is looking at recalibrating IP incentives. Intellectual Property fuels medical innovations from the research bench to the patient’s bedside.
New European drug factories will be greener and more efficient than the old ones — and their products more expensive.
A draft copy of the new National Defense Industrial Strategy says American companies can’t build weapons fast enough to meet global demand.
The European Commission argues that the upcoming pharmaceutical revision must not favour incentives to industry over the availability of medicines, while drug manufacturers warn that in pharmaceutical research and development, Europe is already lagging…
Notre newsletter quotidienne sur les enjeux de lobbying et de transparence en France. Par PAUL DE VILLEPIN Avec ALEXANDRE LÉCHENET et OCÉANE HERRERO Infos, tuyaux et mini-drames à partager ? Ecrivez à Océane Herrero, Aurore Gorius, Alexandre Léchenet et Paul de Villepin | Voir dans votre navigateur LE MENU DU JOUR — Nouveau patron, nouveaux […]
As the world races to electrify and reduce carbon emissions, demand for the silvery-white alkali metal is skyrocketing.
Ambitious new sodium goal, with additional goal for diverse ingredients.
The budget will help to address ‘the most urgent consequences of the crisis in the Middle East,’ the European Commission says.
Europe must take back its leadership and develop a long-term strategy and policies to regain, sustain, and develop life sciences in Europe.
Drugmakers claim that Brussels’ market exclusivity overhaul will reduce R&D investment
SNEAK PEEK — EU leaders look unlikely to agree easily on a four-year €20 billion fund to help Ukraine keep sourcing arms and training its soldiers. — The Commission has opened a consultation on its long-promised European Defence Industrial Strategy. — Sweden has suggested cutting EU spending on space by €1 billion until 2027 in […]
The White House is poised to make an all-hands effort to impose national rules on a fast-moving technology, according to a draft executive order.
Only 4 percent of medicines shortages are related to the research-based pharmaceutical sector.
Increased investment into previously neglected diseases could see poorer countries left behind.
Despite progress, there is now an increase in the cardiovascular disease burden across all major European countries.
A select group of European Parliament lawmakers will on Tuesday quiz Iliana Ivanova, Bulgaria’s designated commissioner for innovation, research, culture, education and youth, to assess whether she’s capable of taking over the portfolio from Mariya Gabriel, who resigned in May to become the country’s deputy prime minister and foreign minister. It’s the first of more […]
While Thierry Breton hailed chip manufacturers’ recent investment pledges in Europe as a ‘culmination’ of the EU’s industrial strategy and its newly-adopted Chips Act, a lot more work is needed.
A major drug pricing crackdown in the US is threatening drug companies’ bottom lines.
There’s nothing original about the idea that the state of the economy decides elections, but when the cost of energy and food are a concern for most people, a governing party is in serious trouble.
Good intentions don’t necessarily translate to good policy, and the bloc’s proposal will make it harder for companies to conduct research and for Europeans to reap the benefits of cutting-edge drugs.
The European Commission and the European Investment Bank announced on Wednesday (12 July) the creation of the HERA Invest initiative, offering €100 million for innovative solutions to future health threats. HERA Invest, a flagship initiative of the Eur…
